A. Maes

400 total citations
17 papers, 285 citations indexed

About

A. Maes is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Spectroscopy. According to data from OpenAlex, A. Maes has authored 17 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Epidemiology and 3 papers in Spectroscopy. Recurrent topics in A. Maes's work include Analytical Chemistry and Chromatography (3 papers), Inhalation and Respiratory Drug Delivery (3 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). A. Maes is often cited by papers focused on Analytical Chemistry and Chromatography (3 papers), Inhalation and Respiratory Drug Delivery (3 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). A. Maes collaborates with scholars based in Belgium, United States and United Kingdom. A. Maes's co-authors include Siska Croubels, Julie De Backer, Patrick Larson, Leanne M. Ward, F. H. Glorieux, S. Aubrey Stoch, J Chodakewitz, Charlotte Sandersen, Arturo G. Porras and John A. Wagner and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Clinical Pharmacology & Therapeutics.

In The Last Decade

A. Maes

17 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Maes Belgium 11 56 54 50 41 31 17 285
M.J. Dennis United States 11 72 1.3× 37 0.7× 32 0.6× 25 0.6× 24 0.8× 14 386
V. Schuermans Belgium 10 49 0.9× 174 3.2× 47 0.9× 31 0.8× 11 0.4× 13 499
Ruth Coxon United Kingdom 10 22 0.4× 72 1.3× 59 1.2× 12 0.3× 12 0.4× 15 317
Marlene Drag United States 12 70 1.3× 18 0.3× 40 0.8× 19 0.5× 4 0.1× 24 421
Masatoshi Ogawa Japan 7 37 0.7× 32 0.6× 159 3.2× 23 0.6× 5 0.2× 29 333
Kousuke Okamoto Japan 14 17 0.3× 128 2.4× 111 2.2× 64 1.6× 4 0.1× 42 487
L Millérioux France 10 92 1.6× 266 4.9× 45 0.9× 36 0.9× 31 1.0× 20 511
Harvey S. Kantor United States 9 132 2.4× 68 1.3× 160 3.2× 32 0.8× 4 0.1× 13 539
Rita Carolina Figueiredo Duarte Brazil 13 21 0.4× 29 0.5× 117 2.3× 16 0.4× 4 0.1× 39 492
Gregory H. Foster United States 10 10 0.2× 74 1.4× 133 2.7× 19 0.5× 16 0.5× 16 532

Countries citing papers authored by A. Maes

Since Specialization
Citations

This map shows the geographic impact of A. Maes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Maes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Maes more than expected).

Fields of papers citing papers by A. Maes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Maes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Maes. The network helps show where A. Maes may publish in the future.

Co-authorship network of co-authors of A. Maes

This figure shows the co-authorship network connecting the top 25 collaborators of A. Maes. A scholar is included among the top collaborators of A. Maes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Maes. A. Maes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chen, Rong, Nanshan Zhong, Wang Hy, et al.. (2020). Efficacy And Safety Of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Formulated Using Co-Suspension Delivery Technology In Chinese Patients With COPD. SHILAP Revista de lepidopterología. 1 indexed citations
2.
3.
4.
Devreese, Mathias, et al.. (2017). Influence of mycotoxin binders on the oral bioavailability of tylosin, doxycycline, diclazuril, and salinomycin in fed broiler chickens. Poultry Science. 96(7). 2137–2144. 12 indexed citations
5.
Haspeslagh, Maarten, Lien Taevernier, A. Maes, et al.. (2016). Topical distribution of acyclovir in normal equine skin and equine sarcoids: An in vitro study. Research in Veterinary Science. 106. 107–111. 8 indexed citations
6.
Xing, D., et al.. (2010). Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines.. PubMed. 2010(1). 51–63. 15 indexed citations
7.
Stoch, S. Aubrey, Evan Friedman, A. Maes, et al.. (2009). Effect of Different Durations of Ketoconazole Dosing on the Single‐Dose Pharmacokinetics of Midazolam: Shortening the Paradigm. The Journal of Clinical Pharmacology. 49(4). 398–406. 38 indexed citations
8.
9.
Hendriksen, Coenraad, Juan Arciniega, Michel Chevalier, et al.. (2007). The consistency approach for the quality control of vaccines. Biologicals. 36(1). 73–77. 51 indexed citations
10.
11.
Maes, A., Tom Meyns, Bart Sustronck, et al.. (2007). Determination of cefquinome in pig plasma and bronchoalveolar lavage fluid by high‐performance liquid chromatography combined with electrospray ionization mass spectrometry. Journal of Mass Spectrometry. 42(5). 657–663. 18 indexed citations
12.
Bergman, Arthur, J Côté, A. Maes, et al.. (2006). PII-46Sitagliptin (MK-0431), a selective dipeptidyl-peptidase-IV (DPP-IV) inhibitor, does not affect the pharmacokinetics of simvastatin in humans. Clinical Pharmacology & Therapeutics. 79(2). P48–P48. 7 indexed citations
13.
14.
Wright, Daniel F. B., A. Maes, Bingming Yi, et al.. (2006). PIII-64Multiple dose administration of MK-0431 (sitagliptin), an inhibitor of dipeptidyl peptidase-IV, does not meaningfully alter the plasma pharmacokinetics or pharmacodynamics of single doses of warfarin. Clinical Pharmacology & Therapeutics. 79(2). P76–P76. 11 indexed citations
15.
Ward, Leanne M., Andrew Denker, Arturo G. Porras, et al.. (2005). Single-Dose Pharmacokinetics and Tolerability of Alendronate 35- and 70-Milligram Tablets in Children and Adolescents with Osteogenesis Imperfecta Type I. The Journal of Clinical Endocrinology & Metabolism. 90(7). 4051–4056. 47 indexed citations
16.
Baert, Kris, Siska Croubels, A. Maes, et al.. (2004). Comparative metabolic excretion profile of sodium salicylate in broiler chickens and homing pigeons. Journal of Veterinary Pharmacology and Therapeutics. 27(2). 123–127. 13 indexed citations
17.
Maes, A., Robert M. Donati, & N. I. Gallagher. (1965). Response of Nephrectomized Rats to Erythropoietin. Experimental Biology and Medicine. 119(3). 802–804. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.J. Dennis Breakdown of academic impact, for papers by V. Schuermans Breakdown of academic impact, for papers by Ruth Coxon Breakdown of academic impact, for papers by Marlene Drag Breakdown of academic impact, for papers by Masatoshi Ogawa Breakdown of academic impact, for papers by Kousuke Okamoto Breakdown of academic impact, for papers by L Millérioux Breakdown of academic impact, for papers by Harvey S. Kantor Breakdown of academic impact, for papers by Rita Carolina Figueiredo Duarte Breakdown of academic impact, for papers by Gregory H. Foster
Rankless by CCL
2026